The applications may concern basic immunology addressing fundamental questions for understanding the biology of the immune system or have a translational potential for understanding, preventing, and/or treating diseases when the immune system has a major role.

 

The List of Reviewers lists all present, whether permanent or temporary, to provide the full scope of expertise present on that date. Lists are posted 30 days before the meeting and are tentative, pending any last minute changes.

Review Dates

Topics


  • Development and function of lymphocytes, such as T, B, NKT, NK cells, innate lymphoid cells (ILCs), and myeloid cells such as dendritic cells and macrophages
  • Initiation of host responses and activation of innate immune cells
  • Antigen processing and presentation by dendritic cells, macrophages, and B cells, T cell receptor (TCR)/major histocompatibility complex (MHC)-peptide interactions
  • T cell differentiation, activation, heterogeneity and plasticity
  • B cell activation and antibody production including interaction between follicular T cells and B cells
  • Antigen-, cytokine-, chemokine- and other ligand-receptor-mediated signaling
  • Transcriptional, posttranscriptional, translational and posttranslational regulation of immune gene expression
  • Immune regulation, inflammation and mechanism of immune-mediated diseases
  • Immunological prevention and treatment of diseases, such as cancers, autoimmunity, allergy and asthma, and infectious diseases
  • Immune evasion in tumors including tumor antigen processing and presentation, innate and adaptive immune responses to tumor cells and tumor-induced immune tolerance
  • Immunology of transplant tolerance and graft-vs-host disease (GVHD)
  • Immunologic development of vaccines against microbial diseases other than HIV

Shared Interests and Overlaps

There are shared interests with Infectious diseases and Microbiology (F13). Applications with focus on host immune response may be reviewed by F07. Studies addressing the pathogen, host-pathogen interactions, pathogenesis, emergence and control of infectious diseases may be reviewed by F13.

There are shared interests with Oncological Sciences (F09). Applications focusing on mechanistic immunological aspects, such as the innate and adaptive immune responses to tumor cells may be reviewed by F07. Applications with an emphasis on translational aspects, such as prevention, diagnosis, development and evaluation of therapeutic strategies may be reviewed by F09.

There are shared interests with Cell Biology, Developmental Biology and Bioengineering (F05). Applications focusing on immunological aspects, such as innate and adaptive immune mechanisms underlying vaccine development or lymphocyte development may be reviewed by F07. Studies with focus on biomaterials development as delivery vectors, computational bioengineering, stem cell biology, or basic principles of cell biology may be reviewed by F05.

There are shared interests with Macromolecular Structure and Function (F04B). Applications focusing on immunological aspects, such as immunological synapse, membrane associated TCR/BCR signaling may be reviewed by F07. Studies with focus on lipid biolayers, membrane architecture, membrane dynamics, trafficking, biophysics, macromolecule folding, macromolecular interaction and signaling may be reviewed by F04.

There are shared interests with Brain Disorders and Related Neurosciences (F01). Applications focusing on immunological topics, such as studies of experimental autoimmune encephalomyelitis (EAE) in a murine model or studies involving neuro-inflammation from an immunology point of view using human multiple sclerosis (MS) patients’ samples may be reviewed by F07. Applications with focus on neuroscience, neuro disease, neuroinflammation, neurological manifestation of systemic lupus erythematosus (SLE), and clinical neuroscience may be reviewed by F01.

There are shared interests with Physiology and Pathobiology of Cardiovascular and Respiratory Systems (F10A). Applications with a focus on lymphocyte development may be assigned to F07. Applications with an emphasis on hematopoietic stem cells, erythropoiesis, atherosclerosis, myelopoiesis associated with cardiovascular diseases, and applications involving immune processes or infection where the target tissue physiology is the readout or endpoints may be reviewed by F10A.